Search the NLPDP Drug Product Database Drug Information Return to NLPDP Drug Database Search Page Return to Results Page Brand Name: Brand NameThis is the name under which the drug product is marketed. TEVA-TERIFLUNOMIDE 14MG TABLET Generic Name: teriflunomide Strength: StrengthThis refers to the amount of the active (medicinal) ingredient (e.g., 50mg, 10 mg/5 mL). 14 mg DIN: DIN A Drug Identification Number (DIN) is an eight digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada. A DIN uniquely identifies the following product characteristics: manufacturer; product name; active ingredient(s); strength(s) of active ingredient(s); pharmaceutical form; route of administration. 02501090 Dosage Form: Dosage FormThe pharmaceutical dosage form is the form of presentation in which the product is supplied for example (e.g.) tablet, capsule, powder, etc.. TABLET Manufacturer: TEVA CANADA LIM Benefit Status: Benefit Status Open - Drugs which are reimbursed with no criteria or prior approval. Note: a drug may have limitations that restrict usage. Special Authorization - Drugs which are only eligible for reimbursement when a Beneficiary meets specific criteria recommended by the Atlantic Common Drug Review (ACDR), the National Common Drug Review (CDR) or the Joint Oncology Drug Review (JODR) Committees. Special Authorization Limitations: LimitationsDrugs which are restricted to those individuals who meet the defined restriction requirements. Eg. Limitation based on age such as children under 12 years of age. None Pricing: PricingPricing for the Newfoundland and Labrador Prescription Drug Program is based upon Defined Cost which is the current published manufacturer’s list price for a drug plus 8.5% (unless otherwise specified). Package Size NLPDP List Price Per Unit 28 16.2737 30 16.2737 Interchangeable Drug Products Interchangeable Drug ProductsInterchangeable drug products means pharmaceutical equivalents or pharmaceutical alternatives that are the therapeutic equivalents of and that have the same route of administration as a reference product. The Newfoundland and Labrador Interchangeable Drug Products Formulary (NIDPF) is a list of commonly used drugs which have therapeutic equivalence to a reference product. AUBAGIO 14 MG TABLET NAT-TERIFLUNOMIDE 14 MG TABLET PMS-TERIFLUNOMIDE 14 MG TABLET MAR-TERIFLUNOMIDE 14 MG TABLET APO-TERIFLUNOMIDE 14 MG TABLET ACH-TERIFLUNOMIDE 14 MG TABLET JAMP TERIFLUNOMIDE 14 MG TAB SANDOZ TERIFLUNOMIDE 14 MG TAB M-TERIFLUNOMIDE 14 MG TABLET Interchangeable Unit Price Interchangeable Unit PriceInterchangeable Unit Price – the lowest unit price of all drug products within an NIDPF category. 16.2737 ATC ATCThe Anatomical Therapeutic Chemical (ATC) is a classification system, where the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties. L04AK02 - TERIFLUNOMIDE Return to NLPDP Drug Database Search Page
